Alzheon

Şirket Açıklaması

We are a clinical stage biopharmaceutical company with a late-stage program in Alzheimer’s disease and a discovery platform of small molecules for the inhibition of protein misfolding and aggregation in neurodegenerative disorders. Protein misfolding is an abnormal process in which a protein fails to fold in its normal configuration, rendering the protein toxic or inactive. Our goal is to develop disease modifying treatments for patients with Alzheimer’s and other neurological disorders by leveraging our expertise in inhibiting protein misfolding and aggregation.

Şirket Genel Bakışı

Şirket AdıAlzheon
Sektörİlaç

IPO Verileri

Tarih22.11.2018
Fiyat$ 4-6
Hisse Senedi Arzı6.000.000
İşlem Hacmi$ 34.500.000
Şirket SembolüALZH
BorsaNASDAQ (NASDAQ)
E-BÜLTEN ABONELİĞİ
Websitemizdeki güncellemeler ve son İPO duyuruları ile ilgili haberdar olmak için e-mail listemize abone olun.
BİZİ TAKİP EDİN
Bizi sosyal medyada takip etmeyi unutmayın